Skip to content
Unrated Medical device recall · FDA · Published November 10, 2020

CryoLife SG Pulmonary Heart Valve Recall: Microbial Test Failures

CryoLife recalls SG Pulmonary Heart Valves with microbial culture test failures in processing. Affected units have specific serial numbers and UDI codes. Consumers should contact CryoLife for details.

🇺🇸 FDA recall #Z-0652-2021Medical deviceCryoLife ›
Take action

Contact the company

Recalling firmCryoLife, Inc.1655 Roberts Blvd Nw · Kennesaw, GA 30144-3632
✎ GovInfoNow plain-language explainer

CryoLife is recalling certain SG Pulmonary Heart Valves due to microbial culture test failures in processing. This could pose a risk of infection or complications after implantation. Read more at govinfonow.com/recall/63946-cryolife-sg-pulmonary-heart-valve-recall-microbial-test-failures.

Source Summary by GovInfoNow · govinfonow.com/recall/63946-cryolife-sg-pulmonary-heart-valve-recall-microbial-test-failures · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0652-2021

Cite this page

“CryoLife SG Pulmonary Heart Valve Recall: Microbial Test Failures.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63946-cryolife-sg-pulmonary-heart-valve-recall-microbial-test-failures. Based on FDA recall #Z-0652-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0652-2021%22&limit=1).

The FDA announced on November 10, 2020, that CryoLife, Inc. is recalling CryoValve SG Pulmonary Human Heart Valves due to post-processing microbial culture test failures. The agency said the issue involves a TRIS saline solution lot used in processing other allografts.

How to tell if you have it

  • Brand: CryoLife
  • Product: CryoValve SG Pulmonary Human Heart Valve
  • Model/Catalog Number: SGPV00
  • Serial Numbers: 11685214, 11685554, and 11682491
  • UDI: 00877234000447
  • Quantity: 3 units
  • Distribution: Nationwide to GA, AZ, TX, MO, and OK

The hazard

The FDA said the recall addresses post-processing microbial culture test failures for allografts processed using a specific TRIS saline solution lot. The agency reported that this same lot was used in processing other allografts subjected to the recall.

Context

GovInfoNow's records show CryoLife, Inc. has 5 other recalls on record since May 14, 2018. Other recent recalls of similar products include On-X Mitral Heart Valve Recall (February 1, 2026), Getinge Thoracic Catheter Recall (August 7, 2026), and Medline Heart Cath Pack-LF Kits Recall (March 24, 2026).

How to tell if you have this one

Check for serial numbers 11685214, 11685554, or 11682491 on the packaging. The unique device identifier (UDI) 00877234000447 also identifies affected units.

  • Brand
    CryoLife
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Distributed nationwide to GA, AZ, TX, MO, and OK.
Recall numberProduct, codes & lotsQuantity
Z-0652-2021CryoValve SG Pulmonary Human Heart Valve. The valve is cryopreserved in a tissue culture medium containing cryoprotectants within the innermost pouch of a three-pouch packaging system. The packaging system not only withstands ultracold temperatures, but also allows for aseptic introduction of the valve into the operating environment. Supercooling by liquid nitrogen boost is begun prior to crystallization to minimize ice crystal damage to the valve matrix. Finally, the valve is transferred to a liquid nitrogen freezer for long-term storage at or below 135¿C. CryoValve SG is distributed in two anatomic configurations: pulmonary valve and conduit, and pulmonary valve.; Model/Catalog Number: SGPV00 Serial Numbers: 11685214, 11685554, and 11682491 UDI: 008772340004473 units
Z-0653-2021CryoPatch SG Pulmonary Human Cardiac Patch. The patch is cryopreserved in a tissue culture medium containing cryoprotectants within the innermost pouch of a three-pouch packaging system. The packaging system not only withstands ultracold temperatures, but also allows for aseptic introduction of the patch into the operating environment. Supercooling by liquid nitrogen boost is begun prior to crystallization to minimize ice crystal damage to the patch matrix. Finally, the patch is transferred for long-term storage at or below 135¿ C. CryoPatch SG is distributed in three anatomic configurations: pulmonary hemi-artery, pulmonary trunk and pulmonary branch.; Model/Catalog Number: SGP020 Serial Numbers: 11677186, 11679112, and 11681763 UDI: 008772340004852 units
Based on the official FDA remedy

What to do — step by step

  1. Contact CryoLife

    Reach out to CryoLife directly to confirm if your valve is affected and get instructions for next steps.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 5 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: nationwideFL

FDA distribution: “Distributed nationwide to GA, AZ, TX, MO, and OK.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Arizona, Georgia, Missouri, Oklahoma, Texas.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

1. Firm started the recall: Nov 10, 202012. FDA classified it Class II: Dec 21, 202023. Published in FDA’s Enforcement Report: Dec 30, 202034. FDA terminated the recall: Oct 26, 2021420202021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0652-2021 (November 10, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0652-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA